isvav_result

publication_year

occurrences__organization__code

solver__id__sc2

result_type__code

Type of result according to the RIV classification. Czech version is available <a href="https://www.vyzkum.cz/FrontClanek.aspx?idsekce=1395" target="_blank" >here</a>.

language__code

Jazyk výsledku udáva původní jazyk, ve kterém byl daný výsledek vytvořen. Kompletní seznam jazyků ve kterém je možno výsledek do RIV předložit je <a href="https://www.vyzkum.cz/FrontClanek.aspx?idsekce=1397" target="_blank" >zde</a>.

cep__code

ford__code

_group_id67

occurrences__funder__code

Data supplier is the R&D aid provider who supported this result.

project__programme__code

x_range_count_solvers

project__id

What are you looking for?

Quick search

Smart search

Filters

Histone deacetylase inhibitors in cancer therapy. A review

Antiproliferative and proapoptotic effects of proteasome inhibitors and their combination with histone deacetylase inhibitors on leukemia cells

Histone Deacetylase Inhibitors as Anticancer Drugs

Therapy of multiple myeloma and myeloma-related kidney disease

Histone deacetylase inhibitors in the treatment of lymphoid malignancies

Quantitative Acetylomics Uncover Acetylation-Mediated Pathway Changes Following Histone Deacetylase Inhibition in Anaplastic Large Cell Lymphoma

A combined approach for the study of histone deacetylase inhibitors

CARM1 Modulators Affect Epigenome of Stem Cells and Change Morphology of Nucleoli

Continuous Activity Assay for HDAC11 Enabling Reevaluation of HDAC Inhibitors

Inhibitory histon-deacetylasy